510(k) · Cleared
ClearedProfile-V Medtoxscan Drugs of Abuse Test System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medtox Diagnostics, Inc. · DJG Enzyme Immunoassay, Opiates
Cleared on Jul 24, 2009 as substantially equivalent to K080635 (Medtox Diagnostics, Inc., 2009) and 3 other predicates after a 67-day review. Its family tree reaches back 3 generations to 2002. 4 later devices descend from it.
- Decided
- Jul 24, 2009
- Review
- 67 days
- Class
- Class II
- Product code
- DJG
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 3 generations to K014101 (2002). 7 ancestors in all, the oldest K973547 (1998). 4 later devices descend from it, 3 citing it directly.
- Root · 3 generations backK014101 Rapidone-Oxy TestAmerican Bio Medica Corp. · 2002
- 2 generations backK040411 Dri Oxycodone AssayMicrogenics Corp. · 2004
- 1 generation backK060351 Medtox OxycodoneMedtox Diagnostics, Inc. · 2006
- This deviceK091454 Profile-V Medtoxscan Drugs of Abuse Test SystemMedtox Diagnostics, Inc. · 2009
- Descendant · cites it directly · 1 of its ownK220451 Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATRandox Laboratories Limited · 2023 · Recalled
- Descendant · 2 generations on · 0 of its ownK250741 Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited · 2026
- Descendant · cites it directly · 0 of its ownK221550 Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited · 2023
- Descendant · cites it directly · 0 of its ownK100023 Profile-V Medtoxscan Drugs of Abuse Test System and 12 Drugs Test…Medtox Diagnostics, Inc. · 2010
Most influential descendants
Showing 4 of 4 · See all- K220451Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATRandox Laboratories Limited · 2023 · cites it directly1descendant
- K250741Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited · 2026 · 2 generations on0descendants
- K221550Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories Limited · 2023 · cites it directly0descendants
- K100023Profile-V Medtoxscan Drugs of Abuse Test System and 12 Drugs Test SystemMedtox Diagnostics, Inc. · 2010 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K014101 | Rapidone-Oxy Test | American Bio Medica Corp. | 2002 | — |
| −2 | K040411 | Dri Oxycodone Assay | Microgenics Corp. | 2004 | — |
| −1 | K060351 | Medtox Oxycodone | Medtox Diagnostics, Inc. | 2006 | — |
| 0 (this device) | K091454 | Profile-V Medtoxscan Drugs of Abuse Test System | Medtox Diagnostics, Inc. | 2009 | — |
| +1 | K220451 | Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTAT | Randox Laboratories Limited | 2023 | 1 |
| +2 | K250741 | Evidence MultiSTAT DOA Urine MultiPlex | Randox Laboratories Limited | 2026 | — |
| +1 | K221550 | Evidence MultiSTAT DOA Urine MultiPlex | Randox Laboratories Limited | 2023 | — |
| +1 | K100023 | Profile-V Medtoxscan Drugs of Abuse Test System and 12 Drugs Test System | Medtox Diagnostics, Inc. | 2010 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1998 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2009 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2010 | 1 | 0 |
| 2023 | 2 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DJG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DJG device
- #1 K232659 Dochek® Multi-Drug Urine Test Cup Rx, Dochek®…score 17.6 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K080635 | MedtoxscanSummary page 1…LDJ 862.3910, Tricyclic Anti-depressant Drugs Test System LFG Predicate Devices: PROFILEe-V MEDTOXScan. Drugs of Abuse Test System (K080635); MEDTOX® OXYCODONE (K060351); VERDICT®-Il PROPOXYPHENE (K020387); PROFILE® -ER (K002331) Description of the Device The PROFILE… | 2009 |
| * | K060351 | Medtox OxycodoneSummary page 1…ricyclic Anti-depressant Drugs Test System LFG Predicate Devices: PROFILEe-V MEDTOXScan. Drugs of Abuse Test System (K080635); MEDTOX® OXYCODONE (K060351); VERDICT®-Il PROPOXYPHENE (K020387); PROFILE® -ER (K002331) Description of the Device The PROFILE®-V MEDTOXScan® Drugs of Abus… | 2006 |
| * | K020787 | Verdict-II Propoxyphene Our reading of the summary gave K020387, FDA’s number for Myallergytest System (Immunetech Corporation). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “VERDICT-II PROPOXYPHENE”. | 2002 |
| * | K002331 | Profile-ERSummary page 1…LFG Predicate Devices: PROFILEe-V MEDTOXScan. Drugs of Abuse Test System (K080635); MEDTOX® OXYCODONE (K060351); VERDICT®-Il PROPOXYPHENE (K020387); PROFILE® -ER (K002331) Description of the Device The PROFILE®-V MEDTOXScan® Drugs of Abuse Test System consists of the PROFILEe-V MEDTOXScan®Test Dev… | 2001 |
What descends from it? (4)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
- 1 of the 7 ancestors has a recall of any class.
- Of its descendants, K220451 (Randox Laboratories Limited, 2023) has gone furthest, with 1 descendant of its own.
- 2 other devices also cite its predicate K080635.
How does its category compare?
All DJG devicesDJG Enzyme Immunoassay, Opiates: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.
FDA decisions per year · DJG
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DJG
31in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DJG
2in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DJG
1in 2025
MAUDE reports naming product code DJG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 0 |
| 2009 | 2 | — | 0 | 0 |
| 2010 | 6 | 187 | 0 | 0 |
| 2011 | 6 | 233 | 1 | 4 |
| 2012 | 5 | 95 | 0 | 1 |
| 2013 | 5 | 60 | 0 | 4 |
| 2014 | 9 | 62 | 0 | 0 |
| 2015 | 12 | 141 | 0 | 3 |
| 2016 | 2 | — | 0 | 2 |
| 2017 | 4 | 101 | 0 | 1 |
| 2018 | 5 | 134 | 0 | 1 |
| 2019 | 3 | 235 | 1 | 0 |
| 2020 | 5 | 30 | 0 | 0 |
| 2021 | 3 | 422 | 0 | 2 |
| 2022 | 2 | — | 0 | 1 |
| 2023 | 10 | 140 | 0 | 0 |
| 2024 | 5 | 150 | 0 | 3 |
| 2025 | 3 | 31 | 2 | 1 |
| 2026 | 3 | 157 | 0 | — |
What is it indicated for?
The PROFILE®-V MEDTOXScan® Drugs of Abuse Test System consists of the PROFILE®-V MEDTOXScan® Test Devices and the MEDTOXScan® Reader. The PROFILE®-V MEDTOXScan® Test Devices are one-step immunochromatographic tests for the rapid, qualitative detection of one or more of the following in human urine: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methadone, Methamphetamine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, THC (Cannabinoids), and…
Read the full statement (382 words)
The PROFILE®-V MEDTOXScan® Drugs of Abuse Test System consists of the PROFILE®-V MEDTOXScan® Test Devices and the MEDTOXScan® Reader. The PROFILE®-V MEDTOXScan® Test Devices are one-step immunochromatographic tests for the rapid, qualitative detection of one or more of the following in human urine: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methadone, Methamphetamine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, THC (Cannabinoids), and Tricyclic Antidepressants or their metabolites. The PROFILE®-V MEDTOXScan® Test Devices can only be used with the MEDTOXScan® Reader. The MEDTOXScan® Reader is an instrument used to interpret and report the results of the PROFILE®-V MEDTOXScan® Test Device. PROFILE®-V MEDTOXScan® Test Devices cannot be visually read.
The PROFILE®-V MEDTOXScan® Drugs of Abuse Test System is for in vitro diagnostic use and is intended for professional use only. It is not intended for use in point-of-care settings.
The PROFILE®-V MEDTOXScan® Drugs of Abuse Test System detects drug classes at the following cutoff concentrations:
AMP Amphetamine (d-Amphetamine) 500 ng/mL; OPI Opiates (Morphine) 100 ng/mL; BAR Barbiturates (Butalbital) 200 ng/mL; OXY Oxycodone (Oxycodone) 100 ng/mL; BZO Benzodiazepines (Nordiazepam) 150 ng/mL; PCP Phencyclidine (Phencyclidine) 25 ng/mL; COC Cocaine (Benzoylecgonine) 150 ng/mL; PPX Propoxyphene (Norpropoxyphene) 300 ng/mL; MAMP Methamphetamine (d-Methamphetamine) 500 ng/mL; THC Cannabinoids (11-nor-9-carboxy-Δ9-THC) 50 ng/mL; MTD Methadone (Methadone) 200 ng/mL; TCA Tricyclic Antidepressants (Desipramine) 300 ng/mL.
Configurations of the PROFILE®-V MEDTOXScan® Test Devices may consist of any combination of the above listed and previously cleared drugs. Refer to specific product labeling for the combination of drug tests included on that test device.
THE PROFILE®-V MEDTOXScan® DRUGS OF ABUSE TEST SYSTEM PROVIDES ONLY A PRELIMINARY ANALYTICAL TEST RESULT. A MORE SPECIFIC ALTERNATE CHEMICAL METHOD MUST BE USED IN ORDER TO OBTAIN A CONFIRMED ANALYTICAL RESULT. GAS CHROMATOGRAPHY / MASS SPECTROMETRY (GC/MS), HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) OR LIQUID CHROMATOGRAPHY / TANDEM MASS SPECTROMETRY (LC/MS/MS) ARE THE PREFERRED CONFIRMATORY METHODS. CLINICAL CONSIDERATION AND PROFESSIONAL JUDGMENT SHOULD BE APPLIED TO ANY DRUG OF ABUSE TEST RESULT, PARTICULARLY WHEN PRELIMINARY POSITIVE RESULTS ARE OBTAINED.
The MEDTOXScan® Reader includes a Positive QC Test Device, a Negative QC Test Device and a Cleaning Cassette. The MEDTOXScan® Positive and Negative QC Test Devices are intended to detect errors associated with the MEDTOXScan® Reader and a contaminated contact imaging sensor (CIS), and to verify that the CIS cleaning procedure using the MEDTOXScan® Cleaning Cassette effectively removed any contamination.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K091454 · printed Nov 6, 2026
Cite this page
510(k) Report. “K091454: Profile-V Medtoxscan Drugs of Abuse Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K091454
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026